Association between Polyphenol Intake and Breast Cancer Risk by Menopausal and Hormone Receptor Status

Vitelli-Storelli, Fecundo
Zamora Ros, Raul
Fernández Villa, Tania
Castelló, Adela
Barrio, Juan Pablo
Amiano, Pilar
Ardanaz, Eva
Obón Santacana, Mireia
Gómez Acebo, Inés
Molina Barceló, Ana
Alguacil, Juan
Ruiz Moreno, Emma
Pedraza, Manuela
Gil, Leire
Guevara, Marcela
Castaño-Vinyals, Gemma
Dierssen Sotos, Trinidad
Kogevinas, Manolis
Aragonés, Nuria
Martín, Vicente
Share
There is limited evidence of phenolic compounds acting as protective agents on several cancer types, including breast cancer (BC). Nevertheless, some polyphenol classes have not been investigated and there is a lack of studies assessing the effect on menopausal status and hormone receptor status as influenced by these compounds. The objective of this study is to evaluate the association between the intake of all polyphenol classes in relation to the BC risk by menopausal and hormone receptor status. We used data from a population-based multi-case-control study (MCC-Spain) including 1472 BC cases and 1577 controls from 12 different regions of Spain. The odds ratios (ORs) with 95% CI were calculated using logistic regression of mixed effects by quartiles and log2 of polyphenol intakes (adjusted for the residual method) of overall BC, menopausal and receptor status. No associations were found between total intake of polyphenols and BC risk. However, inverse associations were found between stilbenes and all BC risk (ORQ4 vs. Q1: 0.70, 95%CI: 0.56–0.89, Ptrend = 0.001), the consumption of hydroxybenzaldehydes (ORQ4 vs. Q1: 0.75, 95%CI: 0.59–0.93, Ptrend = 0.012) and hydroxycoumarins (ORQ4 vs. Q1: 0.73, 95%CI: 0.57–0.93; Ptrend = 0.005) were also inversely associated. The intake of stilbenes, hydroxybenzaldehydes and hydroxycoumarins can contribute to BC reduction risk on all menopausal and receptor statuses ​
This document is licensed under a Creative Commons:Attribution (by) Creative Commons by4.0